• Products
    • Pritumumab
    • CLNH5
    • MultiPharm
  • Investors
    • Corporate Governance
    • Contact Investor Relations
  • News
  • About
    • Corporate Management
    • Board of Directors
    • Science Advisory Board
  • Contact
Development and delivery of human antibodies for the treatment of cancer Development and delivery of human antibodies for the treatment of cancer Development and delivery of human antibodies for the treatment of cancer
  • Products
    • Pritumumab
    • CLNH5
    • MultiPharm
  • Investors
    • Corporate Governance
    • Contact Investor Relations
  • News
  • About
    • Corporate Management
    • Board of Directors
    • Science Advisory Board
  • Contact

Archives

Monthly Archive for: "September, 2020"
 Nascent Biotech Research Collaboration Partner, Manhattan BioSolutions, Receives Grant for Covid 19 Vaccine Studies
0
By Nascent Biotech
In Corporate News, News, Press Releases
Posted September 24, 2020

Nascent Biotech Research Collaboration Partner, Manhattan BioSolutions, Receives Grant for Covid 19 Vaccine Studies

SAN DIEGO, CA / ACCESSWIRE / September 23, 2020 / Nascent Biotech, Inc (OTCQB:NBIO), a biotechnology company pioneering innovative medicines to overcome difficult-to-treat cancers and viral [...]

READ MORE
© NASCENT BIOTECH, INC. ALL RIGHTS RESERVED.